Bladder Cancer Forum 2023

Recording from March 31 - April 1, 2023 / Kingston, Ontario

Meeting Co-Chairs

Madhuri Koti
Queen’s Cancer Research Institute
Srikala Sridhar
UHN, Department of Medical Oncology

Steering Committee

David Berman
Queen’s University, Department of Pathology and Molecular Medicine
Peter Black
Vancouver Prostate Centre
Tony Cornacchia
Bladder Cancer Canada
Wassim Kassouf
McGill University, Department of Surgery, Division of Urology
Girish Kulkarni
University of Toronto, Department of Surgery, Division of Urology
Robert Purves
Bladder Cancer Canada
Robert Siemens
Queen’s University, Department of Urology

Learning Objectives

• Understand the current state of knowledge on the BCG mode of action and novel immunotherapies beyond BCG for NMIBC
• Understand current and emerging imaging approaches in NMIBC and MIBC
• Understand how biomarkers are being incorporated into the management of metastatic urothelial cancer (mUC) and discuss clinical management of mUC cases
• Understand novel immune evasion mechanisms underlying bladder cancer progression and novel therapies targeting them
• Understand novel immune-based approaches in preclinical and early clinical stages of evaluation in bladder cancer

View final program >>